NCT06194006 · NOT YET RECRUITING
Long Term Follow-up Grafted Huntington's Disease Patients
This study is following Huntington's disease patients who already received experimental brain cell transplants (intrastriatal allografts) under an earlier trial called MIG-HD. Researchers want to track how those patients are doing long-term — looking at whether the transplants helped, caused side effects, or triggered immune reactions. This is a follow-up observational study, not a new treatment trial. No intervention is being given; it is purely monitoring.
You may qualify if
- Adult patients transplanted under the MIG-HD protocol
- Information and informed consent from patients or their representative
- Affiliation with a social security scheme or beneficiary
You're excluded if
- Patient under AME
- Patient unable to express consent and not subject to legal protection
- Knowned pregnancy or breastfeeding woman
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-01-08